Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
about
Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)Striving for optimal bronchodilation: focus on olodaterolPharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDTargeting aerosol deposition to and within the lung airways using excipient enhanced growthA systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo DataPatient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerEfficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studiesHigher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.Clinical effectiveness of the Respimat inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devicesQuestionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switchNumerical Model to Characterize the Size Increase of Combination Drug and Hygroscopic Excipient Nanoparticle AerosolsCardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways.Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease.Use of Respimat Soft Mist inhaler in COPD patientsIn vitro and in vivo aspects of cascade impactor tests and inhaler performance: a reviewAsthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.Tiotropium for adults with inadequately controlled persistent asthma.Inhaler devices for patients with COPD.Aerosol therapy in children: challenges and solutions.Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery.Formulation considerations for dry powder inhalers.Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.The case for impulse oscillometry in the management of asthma in children and adults.The function and performance of aqueous aerosol devices for inhalation therapy.The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.Fluticasone furoate and vilanterol trifenatate combination therapy for the treatment of asthma.Tiotropium bromide as add-on therapy to inhaled corticosteroids for treating asthma.Development of Respimat(®) Soft Mist™ Inhaler and its clinical utility in respiratory disorders.A pharmacokinetic simulation tool for inhaled corticosteroids.Pharmacokinetics and tolerability (Study 1) with particular reference to ocular safety (Study 2) of tiotropium Respimat soft mist inhaler: findings from two dose-ranging studies in healthy men.Relationship between lung function and inhalation devices for LAMA/LABA therapy for chronic obstructive pulmonary disease.Small airway involvement in the late allergic response in asthma.Continued Innovation in Respiratory Care: The Importance of Inhaler Devices.Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease
P2860
Q26738366-E5B525B7-AD30-46F7-9CF3-4B44F930CF2CQ26752887-210F6710-584D-4296-826C-234A02CAF82BQ26778685-82E69178-41DC-44A8-86BE-CFDA07BC463CQ28390979-51B88BE3-5CDF-4707-8D7A-5BD5AF7FECF9Q30820402-93D187AB-3173-4F0C-A24E-487CF369D0ABQ30945192-8B5B0A01-B380-403F-A703-56EE34CC94A8Q33693426-42D40607-C718-4574-87EC-2EACEE469B9EQ34065963-144830D3-4202-424E-A7CA-FE6021FFDCF0Q34605346-0965D421-704B-4DF0-BCA9-10D4D7BB8E8AQ34721292-EDAAB2F1-A207-4157-8238-CE0C2CFA6915Q34944616-D9092D5A-CF1B-414F-8337-08A5E00677D2Q35127772-A9026FB1-857D-400C-931B-93E6179512EBQ35762406-8B4330E6-44B7-423F-800D-1B683441B9ADQ36417205-31734010-EAE5-43F7-B4DE-4D6E7BB8A84DQ36813641-4AD385B3-0D25-4733-AE75-7A4C790821FDQ37018826-5FB47D1A-008D-4A65-A2DB-FA0DED4E39C2Q37052973-9856E6F0-B2EA-4B1E-B73C-D793CB4C9E1AQ37236169-3ECD0570-5E10-40DE-A5E8-1491B523588AQ37236599-1C91F2E9-4F72-4F99-AA55-F3BE083DBA9BQ38074513-318BE629-ECF7-450D-B72D-2AADCBB930D3Q38093853-CE659FDA-B645-4C32-AF22-31169AB43C56Q38162255-6F8B816C-4A47-4C9F-92E7-B7F09E3587C6Q38175421-BBD6DF8D-B806-437B-95DE-A93FBC1108A6Q38236695-3A5CA5F2-8805-499F-8FAD-247937B5FAB0Q38258538-26FCBF25-16A1-440D-8C31-52D340EA10E0Q38742722-FB44463E-658D-4599-BE2E-872C436F1E8FQ38803035-62A5A431-5157-4AD7-912F-0EEC46F564A6Q38980035-1562663E-8F3F-4FA6-93A0-64DCE84F405EQ40661319-A2560408-FBCE-49FA-9F82-3D0670ECACD0Q41722430-F018AC40-E5D3-44EF-9A62-E1EC330AA90BQ42119060-F3EF5C44-4A35-46D5-9521-3CF592BA0A3EQ42507245-73EDF24A-B118-4AE3-AB89-14B192B400C8Q43195021-1D1EA5A2-3F0F-4335-AE31-0C2E7DA74DFCQ47706957-A92F6920-AE2C-44BD-8303-A94E72E4F521Q47764643-8BEF409A-432A-446D-BBBD-94F4FE2772ABQ53424005-4CDB5D98-7458-4B63-B743-9E80C0081AC6Q58272064-90F8B452-650C-4ADD-9E51-8B40D9200B71
P2860
Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Deposition of corticosteroid a ...... Turbuhaler dry powder inhaler.
@en
Deposition of corticosteroid a ...... Turbuhaler dry powder inhaler.
@nl
type
label
Deposition of corticosteroid a ...... Turbuhaler dry powder inhaler.
@en
Deposition of corticosteroid a ...... Turbuhaler dry powder inhaler.
@nl
prefLabel
Deposition of corticosteroid a ...... Turbuhaler dry powder inhaler.
@en
Deposition of corticosteroid a ...... Turbuhaler dry powder inhaler.
@nl
P2093
P356
P1476
Deposition of corticosteroid a ...... Turbuhaler dry powder inhaler.
@en
P2093
Demetri Pavia
Gary Pitcairn
Sandie Reader
Steve Newman
P304
P356
10.1089/JAM.2005.18.264
P577
2005-01-01T00:00:00Z